Description
An inhibitor of the 3β-HSDs: 3β-HSD1 and 3β-HSD2 (Kis = 0.10 and 1.60 μM, respectively); approved for use in reducing cortisol, aldosterone, and corticosterone levels in dogs diagnosed with Cushing’s syndrome; may potentially benefit the treatment of breast cancer in postmenopausal women
Formal name: 4α,5α-epoxy-3,17β-dihydroxy-androst-2-ene-2-carbonitrile
Synonyms: Desopan|Modrefen|Vetoryl|WIN 24,540
Molecular weight: 329.4
CAS: 13647-35-3
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Lipids|Sterol Lipids||Product Type|Biochemicals|Small Molecule Inhibitors|Sterol Biosynthesis||Research Area|Cancer||Research Area|Endocrinology & Metabolism|Hormones & Receptors|Estrogens & Progestins||Research Area|Endocrinology & Metabolism|Hormones & Receptors|Glucocorticoids & Mineralocorticoids||Research Area|Lipid Biochemistry|Sterol Lipids